outbrain
Close  

US Army and France’s Sanofi combine work on Zika vaccine

/ 05:12 PM July 06, 2016
In this Feb. 11, 2016 file photo of aedes aegypti mosquitoes are seen in a mosquito cage at a laboratory in Cucuta, Colombia. An experimental vaccine for the Zika virus is due to begin human testing in coming weeks, after getting the green light from U.S. health officials. AP

In this Feb. 11, 2016 file photo of aedes aegypti mosquitoes are seen in a mosquito cage at a laboratory in Cucuta, Colombia. An experimental vaccine for the Zika virus is due to begin human testing in coming weeks, after getting the green light from U.S. health officials. AP

PARIS — Pharmaceutical giant Sanofi says it is joining efforts with U.S. Army researchers to speed up development of a potential Zika vaccine.

France-based Sanofi SA said in a statement Wednesday that the Walter Reed Army Institute of Research will transfer its Zika vaccine technology to Sanofi Pasteur, the company’s vaccine arm. Sanofi views the agreement as “opening the door for a broader collaboration with the U.S. government.”

ADVERTISEMENT

Financial details were not disclosed.

Vaccine development usually takes years. Sanofi made the first vaccine shot against dengue — which is related to Zika — but it required 20 years of development and $1 billion. Sanofi and U.S. researchers are trying to leverage experience with related viruses to accelerate work on Zika amid the current outbreak of the mosquito-borne virus across the Americas. TVJ

FEATURED STORIES

TOPICS: dengue, pharmaceutical giant, rare disease, Sanofi, Sanofi Pasteur, technology, us army, vaccine shot, Vaccine Technology, Walter Reed Army Institute of Research, Zika vaccine, Zika vaccine technology
Read Next
EDITORS' PICK
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2020 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.